Gilead Sciences, Inc.
GILD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment ofā¦ read more
Healthcare
Drug ManufacturersāGeneral
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$118.37
Price-0.55%
-$0.65
1Y
Price
Market Cap
$146.875b
Large
Price/Earnings 3y Avg5y Avg
15.3x
Premium
Premium
Financials Overview
Key metrics over the past few years+39.1%
EBITDA Margin+19.7%
Net Profit Margin+24.8%
Free Cash Flow MarginRevenue
$28.734b
-0.1%
1y CAGR+1.8%
3y CAGR+1.3%
5y CAGREarnings
$5.965b
+1142.7%
1y CAGR+358.2%
3y CAGR+262.1%
5y CAGREPS
$4.75
+1150.0%
1y CAGR+360.7%
3y CAGR+264.0%
5y CAGRBook Value
$19.078b
$56.434b
Assets$37.356b
Liabilities$24.952b
DebtDebt to Assets
44.2%
2.4x
Debt to EBITDAFree Cash Flow
$9.844b
-4.5%
1y CAGR+7.8%
3y CAGR+0.1%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company